ArticleJournal of neuro-oncology2014

Activation of ErbB2- ErbB3 signaling pathway supports potential therapeutic activity of ErbB inhibitors in AT/RT.

Simone Treiger Sredni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.